R&D Bioconvergence & future human health, with Shai Melcer Shai Melcer discusses bioconvergence, a multidisciplinary research and development approach that merges technologies.
R&D One Health: The interconnection of animal and human health There’s a tendency to overlook the fact that human health and animal health are closely intertwined.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.